Skip to main content
Bio-Techne10-Q: Capex increase

Bio-Techne plans $7M in capital expenditures for remainder of fiscal 2026 to increase capacity.

What happened

The company has budgeted approximately $7 million for capital expenditures for the rest of fiscal 2026.

Source

SEC EDGARMay 6, 2026

Quarterly report (Form 10-Q)

Bio-Techne 10-Q

Filing excerpt

Capital expenditures for the remainder of fiscal 2026 are expected to be approximately $7 million.

sec.gov/Archives/edgar/data/842023/000110465926056302/tech-20260331x1...Read the full source

Other signals in this filing (4)

Extracted by Autobound

From the Signal API record
Signal
10-Q: Capex increase

What this signalsFilings often name leadership changes, deals and spending plans.

Filed
May 6, 2026

More 10-Q signals at other companies

The full record

From the Signal API record

Numbers

Dollar figure
$7M (Expected capital expenditures for the remainder of fiscal 2026)

Details

CIK
842023
Accession number
0001104659-26-056302
Timeframe
Current year
Filing year
2026
Fiscal year
0
Why it matters
Budget available
Signal category
Financial

Extraction

Confidence
High
Relevance
80%
Sentiment
Positive
Detected
May 12, 2026
signal_type
sec-10q
signal_subtype
capexIncrease

Use this data

Get every 10-Q signal for Bio-Techne and the companies you sell to, in the tools you already use.

  1. Ask Claude about it

    Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Bio-Techne this week?”

  2. Send it to your own tools

    The Signal API returns 10-Q signals for any list of companies as JSON, for your CRM, warehouse or app.

  3. Try it free

    Sign up and spend your free credits on the companies you sell to.

    Start Free1,000 free credits

The API returns more than this page shows

This page shows a preview. The full sec-10q record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.

Company

  • linkedin_urlValue in the API
  • industriesValue in the API
  • employee_count_lowValue in the API
  • employee_count_highValue in the API
  • revenueValue in the API
  • descriptionValue in the API

Signal

  • signal_nameValue in the API
  • associationValue in the API
Show the full JSONThe record on this page and the API request

GET /v1/signals/f6f45866-bc27-45cf-8f2a-6ec4a216b1bd returns this record as JSON. POST /v1/companies/enrich returns every signal for bio-techne.com.

{
  "signal_id": "f6f45866-bc27-45cf-8f2a-6ec4a216b1bd",
  "signal_type": "sec-10q",
  "signal_subtype": "capexIncrease",
  "detected_at": "2026-05-12T09:24:56.699+00:00",
  "company": {
    "name": "Bio-Techne",
    "domain": "bio-techne.com"
  },
  "data": {
    "detail": "The company has budgeted approximately $7 million for capital expenditures for the rest of fiscal 2026. These investments are aimed at increasing production capacity to support anticipated sales growth, indicating available budget for facility upgrades, equipment, and related operational technology.",
    "metrics": {
      "timeframe": "current_year",
      "dollar_context": "Expected capital expenditures for the remainder of fiscal 2026",
      "dollar_millions": 7
    },
    "summary": "Bio-Techne plans $7M in capital expenditures for remainder of fiscal 2026 to increase capacity.",
    "excerpts": "Capital expenditures for the remainder of fiscal 2026 are expected to be approximately $7 million.",
    "relevance": 0.8,
    "sentiment": "positive",
    "confidence": "high",
    "source_url": "https://www.sec.gov/Archives/edgar/data/842023/000110465926056302/tech-20260331x10q.htm",
    "filing_date": "2026-05-06",
    "filing_year": 2026,
    "fiscal_year": 0,
    "sales_relevance": "Budget available",
    "signal_category": "financial"
  }
}

Long text fields are shortened on this page.

Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.